Changes in pulmonary blood flow affect vascular response to chronic hypoxia in rats.

MRabinovitch , STreves , M AKonstam , M JAronovitz
Circulation Research

1983
Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis

Mary Anne Opavsky , Marlene Rabinovitch , Tami Martino , Peter P. Liu
Journal of Clinical Investigation 109 ( 12) 1561 -1569

89
2002
Relevant issues in the pathology and pathobiology of pulmonary hypertension

Rubin M Tuder , Stephen L Archer , Peter Dorfmüller , Serpil C Erzurum
Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır 42 5 -16

586
2014
Subversion of cellular autophagosomal machinery by RNA viruses.

William T Jackson , Thomas H Giddings , Matthew P Taylor , Sara Mulinyawe
PLOS Biology 3 ( 5)

898
2005
Cellular and molecular pathobiology of pulmonary arterial hypertension.

Marc Humbert , Nicholas W Morrell , Stephen L Archer , Kurt R Stenmark
Journal of the American College of Cardiology 43 ( 12)

2,002
2004
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor

Kyle Northcote Cowan , Adrian Heilbut , Tilman Humpl , Catherine Lam
Nature Medicine 6 ( 6) 698 -702

336
2000
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome

Kiichi Nakahira , Jeffrey Adam Haspel , Vijay A K Rathinam , Seon-Jin Lee
Nature Immunology 12 ( 3) 222 -230

2,603
2011
Epidermal Growth Factor Receptor Blockade Mediates Smooth Muscle Cell Apoptosis and Improves Survival in Rats With Pulmonary Hypertension

Sandra L. Merklinger , Peter L. Jones , Eliana C. Martinez , Marlene Rabinovitch
Circulation 112 ( 3) 423 -431

201
2005
Ventilatory predictors of pulmonary hypoplasia in congenital diaphragmatic hernia, confirmed by morphologic assessment

Desmond Bohn , Masanori Tamura , Donald Perrin , Geoffrey Barker
The Journal of Pediatrics 111 ( 3) 423 -431

224
1987
Molecular pathogenesis of pulmonary arterial hypertension

Marlene Rabinovitch
Journal of Clinical Investigation 118 ( 7) 2372 -2379

666
2008
Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease

Kyle Northcote Cowan , Peter Lloyd Jones , Marlene Rabinovitch
Journal of Clinical Investigation 105 ( 1) 21 -34

337
2000
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension

Edda Spiekerkoetter , Xuefei Tian , Jie Cai , Rachel K Hopper
Journal of Clinical Investigation 123 ( 8) 3600 -3613

399
2013
The structural basis of persistent pulmonary hypertension of the newborn infant

John D. Murphy , Marlene Rabinovitch , Jeffrey D. Goldstein , Lynne M. Reid
The Journal of Pediatrics 98 ( 6) 962 -967

267
1981
An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension

Georg Hansmann , Vinicio A de Jesus Perez , Tero-Pekka Alastalo , Cristina M Alvira
Journal of Clinical Investigation 118 ( 5) 1846 -1857

287
2008
S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy

Steven Greenway , Robert Jan van Suylen , Gideon Du Marchie Sarvaas , Edwin Kwan
American Journal of Pathology 164 ( 1) 253 -262

120
2004
Interdependent Serotonin Transporter and Receptor Pathways Regulate S100A4/Mts1, a Gene Associated With Pulmonary Vascular Disease

Allan Lawrie , Edda Spiekerkoetter , Eliana C. Martinez , Noona Ambartsumian
Circulation Research 97 ( 3) 227 -235

134
2005
Overexpression of the Serine Elastase Inhibitor Elafin Protects Transgenic Mice From Hypoxic Pulmonary Hypertension

Syed H.E. Zaidi , Xiao-Mang You , Sorana Ciura , Mansoor Husain
Circulation 105 ( 4) 516 -521

153
2002